Matt Murphy
Manager of Investor Relations
Replay available
Cara Therapeutics, Inc. (CARA) Q3 2023 Earnings Call
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2023 earnings conference call, held 2023-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Posner
Chief Executive Officer
Ryan Maynard
Chief Financial Officer
Dr. Joanna Consalves
Chief Medical Officer
Sumant Kalkani
Analyst at Canaccord Genuity
Tim David
Analyst at Piper Sandler
Annabelle Samimi
Analyst at Stainful
Oren Livnet
Analyst at HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.209 -- 00:00:05.210 Good afternoon. My name is Lateef, and I will be your conference facilitator. 00:00:05.210 -- 00:00:10.392 I would like to welcome everyone to the CARA Therapeutics third quarter financial results 00:00:10.392 -- 00:00:15.413 and update conference call. All lines have been placed on mute to avoid any 00:00:15.413 -- 00:00:21.415 background noise. After the speaker remarks, there will be a question and answer session. 00:00:21.415 -- 00:00:25.996 If you would like to ask a question during this time, simply press star and the numbers 00:00:25.996 -- 00:00:31.037 one one on your telephone keypad. To remove your name from the queue, simply 00:00:31.037 -- 00:00:36.279 press star and the numbers 11 again. Please be advised that this call 00:00:36.279 -- 00:00:41.341 is being recorded. I would now like to introduce Matt Murphy, CARA's Manager of 00:00:41.341 -- 00:00:46.502 Investor Relations. Mr. Murphy, you may begin your call. 00:00:46.683 -- 00:00:51.725 Thank you, Operator, and good afternoon. After market closed today, CARA issued a 00:00:51.725 -- 00:00:56.507 news release announcing the company's financial and operating results for the third quarter 00:00:56.507 -- 00:00:58.517 of 2023. 00:00:58.533 -- 00:01:03.514 Copies of this news release and the associated SEC filing can be found in the investor 00:01:03.514 -- 00:01:07.535 section of our website at www.caratherapeutics.com. 00:01:09.156 -- 00:01:13.837 Before we begin, let me remind you that during the course of this conference call, we 00:01:13.837 -- 00:01:19.018 will be making certain forward-looking statements about CARA and our programs based 00:01:19.018 -- 00:01:22.459 on management's current plans and expectations. 00:01:22.459 -- 00:01:28.584 These statements are b...